
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.410 | 87.650 | 86.240 |
Shares | 97.740 | 97.780 | 0.040 |
Bonds | 0.030 | 0.030 | 0.000 |
Other | 0.820 | 0.820 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.836 | 19.929 |
Price to Book | 3.196 | 3.919 |
Price to Sales | 1.621 | 2.270 |
Price to Cash Flow | 12.612 | 15.391 |
Dividend Yield | 2.651 | 1.437 |
5 Years Earnings Growth | 9.917 | 10.972 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 49.670 | 94.463 |
Financial Services | 23.390 | 8.054 |
Consumer Cyclical | 15.090 | 6.989 |
Consumer Defensive | 4.680 | 3.338 |
Real Estate | 2.880 | 1.309 |
Technology | 2.580 | 4.374 |
Industrials | 1.720 | 2.883 |
Number of long holdings: 159
Number of short holdings: 102
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Allianz | DE0008404005 | 3.14 | 341.60 | -0.44% | |
Sun Life Financial | CA8667961053 | 3.02 | 87.29 | -1.27% | |
MetLife | US59156R1086 | 2.82 | 77.35 | -2.08% | |
Eli Lilly | US5324571083 | 2.74 | 819.36 | +0.90% | |
SCI | US8175651046 | 2.71 | 78.48 | -2.08% | |
BlackRock | US09290D1019 | 2.69 | 971.82 | -1.66% | |
Boston Scientific | US1011371077 | 2.69 | 99.74 | +1.20% | |
Legal & General | GB0005603997 | 2.63 | 252.90 | -0.16% | |
Apple | US0378331005 | 2.52 | 196.45 | -1.38% | |
Novo Nordisk B | DK0062498333 | 2.49 | 516.2 | -0.58% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1530899142 | 3.25B | -10.59 | 6.48 | - | ||
LU2035461495 | 3.25B | -10.40 | 6.80 | - | ||
LU1903290036 | 3.25B | -6.00 | 7.39 | - | ||
LU1530900684 | 3.25B | -10.25 | 7.54 | - | ||
LU1902444402 | 1.81B | -3.59 | 6.45 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review